NCT04906850View on ClinicalTrials.gov

Evaluation of the New Variant 501Y.V2 of COVID-19

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 15, 2021

Study Completion Date

May 15, 2021

Conditions
Covid19
Trial Locations (2)

54000

CHRU Nancy, Nancy

57085

CHR Metz Thionville, Metz

All Listed Sponsors
collaborator

Central Hospital, Nancy, France

OTHER

lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT04906850 - Evaluation of the New Variant 501Y.V2 of COVID-19 | Biotech Hunter | Biotech Hunter